RMAD1, a Novel Cell-Penetrating Peptide Derived from ADARB2: Preclinical Insights into Antigen Uptake and T Cell Activation.

Saved in:
Bibliographic Details
Title: RMAD1, a Novel Cell-Penetrating Peptide Derived from ADARB2: Preclinical Insights into Antigen Uptake and T Cell Activation.
Authors: Lim C; College of Pharmacy, CHA University, 335 Pangyo-ro, Bundang-gu, Seongnam-si, 13488 Gyeonggi-do, Republic of Korea., Park C; Remedi Co., Ltd. Research center, Songdo 21990, Korea., Song EC; Remedi Co., Ltd. Research center, Songdo 21990, Korea., Shin Y; Remedi Co., Ltd. Research center, Songdo 21990, Korea., Kim WK; Remedi Co., Ltd. Research center, Songdo 21990, Korea., Park YJ; Remedi Co., Ltd. Research center, Songdo 21990, Korea., Youn H; College of Pharmacy, CHA University, 335 Pangyo-ro, Bundang-gu, Seongnam-si, 13488 Gyeonggi-do, Republic of Korea., Ham C; Institute for Rare Isotope Science, Institute for Basic Science, Daejeon 34000, Republic of Korea., Kim SB; College of Pharmacy, Sahmyook University, Seoul 01795, Korea., Cho S; Remedi Co., Ltd. Research center, Songdo 21990, Korea.
Source: International journal of biological sciences [Int J Biol Sci] 2026 Jun 04; Vol. 22 (11), pp. 6084-6099. Date of Electronic Publication: 2026 Jun 04 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Ivyspring International Country of Publication: Australia NLM ID: 101235568 Publication Model: eCollection Cited Medium: Internet ISSN: 1449-2288 (Electronic) Linking ISSN: 14492288 NLM ISO Abbreviation: Int J Biol Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1449-2288
DOI:10.7150/ijbs.132948